Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Friedman

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Ophthalmology and Therapy|September 24, 2025
Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical TrialsScott M Friedman, Yingxin Xu, Steven Sherman, et al.
Retina (Philadelphia, Pa.)|May 12, 2010
Diagnostic and therapeutic challengesFernando Ussa, Rosa M Coco, Jose D Paulo, et al.
Retina (Philadelphia, Pa.)|August 14, 2008
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline featuresMichael S Ip, Susan B Bressler, Andrew N Antoszyk, et al.
Ophthalmology and Therapy|June 22, 2026
Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical TrialsScott M Friedman, Yingxin Xu, Steven Sherman, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 25, 2024
Geographic Atrophy Natural History Versus Treatment: Time to FoveaCasey Zhang, Elias Kahan, Tedi Begaj, et al.
JAMA Ophthalmology|October 21, 2021
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical TrialMaureen G Maguire, Danni Liu, Susan B Bressler, et al.
Retina (Philadelphia, Pa.)|January 21, 2015
Topical nepafenec in eyes with noncentral diabetic macular edemaScott M Friedman, Talat H Almukhtar, Carl W Baker, et al.
Ophthalmology|April 5, 2011
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaMichael J Elman, Neil M Bressler, Haijing Qin, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
Ophthalmology|August 19, 2007
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema, Ingrid U Scott, Allison R Edwards, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Ophthalmology and Therapy|September 24, 2025
Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical TrialsScott M Friedman, Yingxin Xu, Steven Sherman, et al.
Retina (Philadelphia, Pa.)|May 12, 2010
Diagnostic and therapeutic challengesFernando Ussa, Rosa M Coco, Jose D Paulo, et al.
Retina (Philadelphia, Pa.)|August 14, 2008
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline featuresMichael S Ip, Susan B Bressler, Andrew N Antoszyk, et al.
Ophthalmology and Therapy|June 22, 2026
Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical TrialsScott M Friedman, Yingxin Xu, Steven Sherman, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 25, 2024
Geographic Atrophy Natural History Versus Treatment: Time to FoveaCasey Zhang, Elias Kahan, Tedi Begaj, et al.
JAMA Ophthalmology|October 21, 2021
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical TrialMaureen G Maguire, Danni Liu, Susan B Bressler, et al.
Retina (Philadelphia, Pa.)|January 21, 2015
Topical nepafenec in eyes with noncentral diabetic macular edemaScott M Friedman, Talat H Almukhtar, Carl W Baker, et al.
Ophthalmology|April 5, 2011
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaMichael J Elman, Neil M Bressler, Haijing Qin, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
Ophthalmology|August 19, 2007
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema, Ingrid U Scott, Allison R Edwards, et al.
Pageof 3